All patients showed marked quickening of gait and noticeably improved balance
Claims involving insomnia, melatonin, telomeres, age reversal, retinal degeneration, cancer prevention or hormone regulation could contribute to medicinal-product classification
PMID: 155 HuCQiaoWLiXNingZLiuJDalangoodSet al
Nu pht hin c nhng triu chng, du hiu bt thng, ngi dng cn ngng s dng sn phm v nhanh chng n gp bc s c h tr
Long-Term Safety Evidence While many peptide therapies have been evaluated only in short-term trials, AOD-9604 benefits from long-term safety data extending to 24 weeks of continuous administration
Reconstitution with bacteriostatic water is required prior to use under controlled laboratory conditions